COVID-19

News

Merck files pill for milder COVID, as AZ showcases its antib...

As expected, Merck & Co has moved ahead swiftly with an emergency use application for its oral antiviral molnupiravir, aiming to protect people with mild or moderate COVID-19 from devel

News

Actemra shortage spills over to include Sanofi's rival Kevza...

Roche's Actemra has been in high demand since its value in treating severe COVID-19 was established, leading to shortages.

Patients

Preparing for a pandemic starts with creating a mentally res...

Janssen UK & Ireland’s managing director Gaëtan Leblay discusses the importance of maintaining the spotlight on our mental health post-pandemic, and why we must hone our mental resilien

News

Moderna unveils $500m plan for African vaccine facility

Moderna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Africa, and has kicked off a search to find a suitable country and location.

News

J&J joins COVID-19 booster shot drive, filing with FDA

Johnson & Johnson's COVID-19 vaccine has been a minor player in the US vaccination drive so far, but the company hopes it can have a bigger role as a booster shot.

News

Targeting COVID-19 and cancer with immunotherapy advancements

EU backs broader use of Comirnaty as COVID booster than US

The EMA has given the go-ahead to the use of Pfizer and BioNTech's COVID-19 vaccine Comirnaty as a booster for all people aged 18 or more, but says EU member states must decide for themselv

Merck files pill for milder COVID, as AZ showcases its antib...

Actemra shortage spills over to include Sanofi's rival Kevza...

Preparing for a pandemic starts with creating a mentally res...

Moderna unveils $500m plan for African vaccine facility

J&J joins COVID-19 booster shot drive, filing with FDA

EU backs broader use of Comirnaty as COVID booster than US

Flagship's AI-focused Generate Biomedicines files IPO

How to meet your physicians where they are online

COVID-19

Editor's Picks